Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Children R Dying
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1175)
•••
Comment by GrahamBon Feb 24, 2021 5:07am
216 Views
Post# 32644438

RE:RE:RE:RE:RE:RE:RE:RE:Children R Dying

RE:RE:RE:RE:RE:RE:RE:RE:Children R Dying
WolfOfTSXStreet wrote:

The company was closed down for a year, they re opened in December and just started with the vms 3.0, they haven't even released their numbers yet, but if you watch the videos posted during podcast you would know where company is

next financials will tell the picture but stop bashing, we have cash for two years btw and a government bursary. Can't stop the green tommorow sorrows 

Cover your shorts, vpt is becoming discovered and I believe is a safe bet in this future of corona and heart diseases 


You haven't said anything new,nor disputed the facts 
Couldn't care if it's green or red-I am not short
Again, all the excuses in the world won't change the fact there are no reported sales and the evidence.
The Chinese deal alone is hard to sort out,and know what the real story is in terms of cash flow to the company-if any .

I will wait until the financials , and hopefully they are audited this time, are out until I decide to buy, notwithstanding the promotions and videos

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities